AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 14, 2026

Neuraxis, Inc NRXS Stock Forecast

AI-powered price prediction and analysis for Neuraxis, Inc · Alpha · vs marketSwitch to Total

Follow
AI 90-Day Forecast ▲ Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence n/a Spearman Correlation

See NRXS's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

NRXS
Fundamentals

Key Statistics

Market Cap$82M
P/B Ratio12.12x
EPS$-0.92
ROE-114.0%
Net Margin-144.4%
Revenue$5M
Current Ratio3.04x
D/E Ratio0.48x
Company

About Neuraxis, Inc

Neuraxis, Inc (NRXS) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry.

Industrial Applications and Services Electromedical & Electrotherapeutic Apparatus NYSE Small Cap
News

Latest News

  • Loading...

Where NRXS sits on the market map

Industrial Applications and Services · Electromedical & Electrotherapeutic Apparatus
Explore the map →
Industry Peers

Electromedical & Electrotherapeutic Apparatus Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
NRXS Neuraxis, Inc ▲ $82M –
MDT Medtronic Plc ▼ $118.97B 22.7x
ITGR Integer Holdings Corp ▼ $4.30B –
LIVN Livanova Plc ▼ $4.21B 22.3x
TMDX Transmedics Group, Inc. ▶ $2.74B 18.1x
AXGN Axogen, Inc. ▲ $1.94B –
ECOR Electrocore, Inc. ▲ $1.91B –
BLFS Biolife Solutions Inc ▶ $1.89B 32.6x
CNMD Conmed Corp ▼ $1.36B –
CBLL Ceribell, Inc. ▲ $1.00B –
INMD Inmode Ltd. ▶ $906M –
CV Capsovision, Inc ▲ $339M –
ELMD Electromed, Inc. ▶ $232M 20.5x
FOCL Edap Tms Sa ▲ $158M –
VANI Vivani Medical, Inc. ▲ $106M –
STXS Stereotaxis, Inc. ▲ $106M –
HYPR Hyperfine, Inc. ▲ $90M –
OM Outset Medical, Inc. ▲ $76M –
POSC Positron Corp ▶ $54M –
VASO Vaso Corp ▲ $51M –
POCI Precision Optics Corporation, Inc. ▲ $50M –
QTI Qt Imaging Holdings, Inc. ▲ $36M –
IRIX Iridex Corp ▲ $15M –
ITOC Itonic Holdings Ltd ▼ $4M –
ADMT Adm Tronics Unlimited, Inc. ▼ $3M –
NXL Nexalin Technology, Inc. ▼ $2M –
ESMC Escalon Medical Corp ▶ N/A –
GTHP Guided Therapeutics Inc ▲ N/A –
HCIL Hongchang International Co., Ltd ▼ N/A –
NDRA Endra Life Sciences Inc. ▶ N/A –
NUWE Nuwellis, Inc. ▼ N/A –
YBGJ Yubo International Biotech Ltd ▼ N/A –
FAQ

FAQ

Is Neuraxis, Inc a good stock to buy?

Our AI analyzes Neuraxis, Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Neuraxis, Inc predictions?

A per-ticker accuracy statistic for NRXS is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Neuraxis, Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Neuraxis, Inc? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.